ELISA Kit for Neurotensin (NT)

NTS; NTS1; NmN-125; NN; Tail peptide Neuromedin N

Specificity

This assay has high sensitivity and excellent specificity for detection of Neurotensin (NT).
No significant cross-reactivity or interference between Neurotensin (NT) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Neurotensin (NT) and the recovery rates were calculated by comparing the measured value to the expected amount of Neurotensin (NT) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 93-101 98
EDTA plasma(n=5) 93-101 97
heparin plasma(n=5) 78-101 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neurotensin (NT) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neurotensin (NT) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Neurotensin (NT) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-101% 79-101% 88-102% 84-102%
EDTA plasma(n=5) 79-103% 96-103% 89-97% 80-94%
heparin plasma(n=5) 81-92% 80-96% 85-97% 99-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1 Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Reagent Diluent 1×300µL Stop Solution 1×6mL
TMB Substrate 1×9mL Instruction manual 1
Wash Buffer (30 × concentrate) 1×20mL

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biomed Research International Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation pubmed:29082242
Molecular Neurobiology Inhibition of Peroxynitrite-induced mitophagy activation attenuates cerebral ischemia-reperfusion injury Pubmed:29307080
Disease Markers Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS
Digestive and Liver Disease Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders Pubmed: 31320306
Biomolecules Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds … Pubmed: 32823854
Biomed Research International Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats … Pubmed: 32626732
Nutrition, Metabolism and Cardiovascular Diseases Identification of U-shaped Curve Relation in Pro-neurotensin and Risk of Coronary Artery Disease (CAD) in Premature CAD Patients
Effect of dobutamine on intrinsic myocardial function and myocardial apoptosis in septic rats with myocardial dysfunction
ACTA PHARMACOLOGICA SINICA Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy 33785860
J Cell Mol Med Elabela gene therapy promotes angiogenesis after myocardial infarction 34291565
Medicina (Kaunas) Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients 34946293
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPB203Mu01 Recombinant Neurotensin (NT) Positive Control; Immunogen; SDS-PAGE; WB.
CPB203Mu21 OVA Conjugated Neurotensin (NT) Immunogen; SDS-PAGE; WB.
CPB203Mu22 OVA Conjugated Neurotensin (NT) Immunogen; SDS-PAGE; WB.
PAB203Mu01 Polyclonal Antibody to Neurotensin (NT) WB; IHC; ICC; IP.
CEB203Mu ELISA Kit for Neurotensin (NT) Enzyme-linked immunosorbent assay for Antigen Detection.
KSB203Mu11 ELISA Kit DIY Materials for Neurotensin (NT) Main materials for "Do It (ELISA Kit) Yourself".